CN111743946B - Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method - Google Patents

Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method Download PDF

Info

Publication number
CN111743946B
CN111743946B CN202010542999.8A CN202010542999A CN111743946B CN 111743946 B CN111743946 B CN 111743946B CN 202010542999 A CN202010542999 A CN 202010542999A CN 111743946 B CN111743946 B CN 111743946B
Authority
CN
China
Prior art keywords
parts
oil
inhalant
refreshing
camphor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010542999.8A
Other languages
Chinese (zh)
Other versions
CN111743946A (en
Inventor
徐雅意
林涛
滕晖
蒋加拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qianjin Pharmaceutical Co ltd
Original Assignee
Qianjin Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qianjin Pharmaceutical Co ltd filed Critical Qianjin Pharmaceutical Co ltd
Priority to CN202010542999.8A priority Critical patent/CN111743946B/en
Publication of CN111743946A publication Critical patent/CN111743946A/en
Application granted granted Critical
Publication of CN111743946B publication Critical patent/CN111743946B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Abstract

The invention belongs to the technical field of daily necessities, and particularly relates to a refreshing and anti-fatigue inhalant composition, an inhalant and a preparation method. The inhalant composition is composed of turpentine, menthol, eucalyptus globulus oil, tiled gaultheria leaf oil, camphor, sweet orange oil and camphor leaf extract according to a certain proportion, and all the components have synergistic effect, so that the inhalant composition can have remarkable and lasting refreshing and anti-fatigue effects even if the inhalant is inhaled through the nose and does not directly contact with the skin, has strong penetrability and richer fragrance types, and is widely accepted and favored in human trial experiments.

Description

Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method
Technical Field
The invention belongs to the technical field of daily necessities. More particularly, relates to an inhalant composition for refreshing and resisting fatigue, an inhalant and a preparation method thereof.
Background
With the rapid development of modern economy and the increasing acceleration of life rhythm, the influence of various factors such as study working pressure, social competition, environmental pollution, season change, dietary structure change, diseases, insomnia and the like is increased, the number of people suffering from various fatigue such as lassitude, weakness, fullness in head, amnesia and the like in people in recent years is increased day by day, and the people are especially long-distance bus drivers, employees working out at night, insomnia patients, students studying for a long time and the like. Therefore, there is an urgent need to improve the sub-health conditions of modern people, such as fatigue, drowsiness, feelings of loss, and inattention, caused by various stresses faced by the modern people in work, study, and life.
At present, most of people who improve fatigue state can refresh by drinking coffee, tea, functional beverage and the like, caffeine contained in the tea can achieve the effects of exciting central nerve, improving brain activity and eliminating fatigue, but the problems of continuously exciting people, penetrating physical energy and addiction exist, and various body discomfort or diseases can be induced after long-term eating. In addition to anti-fatigue beverages, people also commonly use essential oil products to help refreshing and anti-fatigue, for example, chinese patent application CN101879216a discloses a compound natural essential oil with refreshing function, which is prepared from lemon oil, sweet orange oil, rosemary oil, mint essential oil and other components, and has pleasant fragrance and remarkable refreshing effect when in use, but the essential oil products need to be smeared on the skin when in use, so that the skin of a user is easily greasy and heavy, and skin allergy can be caused; chinese patent application CN104815100A discloses a composition with refreshing effect, which is prepared from mint essential oil, lemon essential oil, cassia twig essential oil, wild chrysanthemum flower essential oil and grassleaf sweelflag rhizome essential oil, has good refreshing effect, is beneficial to relieving cachexia, can be prepared into aerosol, spray, nasal inhalant and the like, but when the composition is used as the nasal inhalant, active ingredients do not directly contact with skin, the composition is inhaled only through the nose, the penetrability is weak, the refreshing anti-fatigue effect is small, and the effect is short-lived.
Therefore, there is an urgent need to provide an inhalant composition having strong penetration, a remarkable refreshing and anti-fatigue effect, and a long-lasting effect.
Disclosure of Invention
The invention aims to solve the technical problems that the existing caffeine beverage is low in safety, smearing products are easy to generate discomfort and allergic symptoms, and inhalation products are weak in penetrability and short in effect, and provides an inhalation composition which is strong in penetrability, has remarkable refreshing and anti-fatigue effects and is long in effect.
The invention aims to provide an inhalant composition for refreshing and resisting fatigue.
The invention also aims to provide the application of the composition in preparing daily chemical products or medicines with the refreshing effect.
Another object of the present invention is to provide an inhalant for refreshing and resisting fatigue.
The above purpose of the invention is realized by the following technical scheme:
the inhalant composition for refreshing and resisting fatigue is prepared from the following raw materials in parts by weight: 40-50 parts of turpentine, 5-15 parts of menthol, 4-12 parts of eucalyptus globulus oil, 2-10 parts of spreading beautyberry leaf oil, 2-8 parts of camphor, 2-8 parts of sweet orange oil and 2-8 parts of camphor leaf extract.
In the invention, the turpentine is transparent colorless liquid with fragrance, the main component is terpene, the penetrability is strong, and the turpentine has the effects of promoting blood circulation, resisting bacteria, sterilizing, resisting bronchitis and the like; the menthol is colorless acicular or prismatic crystal or white crystalline powder, has special fragrance of herba Menthae, is cool after initial burning, and has effects of refreshing, relieving itching, diminishing inflammation, relieving pain, promoting blood circulation, etc.; the Eucalyptus globulus Labill oil is clear and transparent, has fresh and penetrating odor, has special woody fragrance of Camphora, contains eucalyptol, linalool, camphora, anethole terpene, and pomelo terpene as main ingredients, and has effects of refreshing, improving skin, and relieving pain; spreading folium Callicarpae Formosanae oil (also called wintergreen oil) which is colorless or yellowish transparent oily liquid, has folium Ilicis Purpureae fragrance, and has antibacterial, insecticidal and antioxidant effects; the camphor is white crystalline powder or colorless transparent hard blocks, has specific penetrating aroma, tastes spicy and cool, has the main component of the dextrocamphor, and has the advantages of cool stimulation, easy absorption and the like; the sweet orange oil is yellow, orange or yellowish-brown liquid, has special orange smell and mild aromatic taste, mainly contains d-limonene, decanal, hexanal, octanol, d-linalool, citral, undecanal, sweet orange aldehyde and the like, and can endow the product with unique fragrance; the folium Cinnamomi Camphorae extract is light yellow powder, and contains Camphora, 1,8-cineole, alpha-terpineol, pinene, geranial, alpha-phellandrene, camphene, neral, etc., and has antibacterial, analgesic, and refreshing effects.
Through a great deal of creative work, the inventor discovers that an inhalant composition which is composed of turpentine, menthol, eucalyptus globulus oil, flat-laid beautyberry leaf oil, camphor, sweet orange oil and camphor leaf extract according to a certain proportion can have remarkable and lasting refreshing and anti-fatigue effects through the synergistic effect of all natural plant components even if the inhalant is inhaled through nose and is not directly contacted with skin, has strong penetrability, can obviously improve the symptoms of fatigue, sleepiness, low mood, inattention and the like of fatigue crowds, enables brains to keep vitality and clear-headed, relieves mood and improves attention.
Preferably, the raw materials for preparing the inhalant composition comprise the following components in parts by weight: 42 to 46 parts of turpentine, 8 to 12 parts of menthol, 5 to 10 parts of eucalyptus globulus oil, 4 to 8 parts of spreading beautyberry leaf oil, 3 to 6 parts of camphor, 3 to 6 parts of sweet orange oil and 3 to 6 parts of camphor leaf extract.
More preferably, the raw materials for preparing the inhalant composition comprise the following components in parts by weight: 45 parts of turpentine, 10 parts of menthol, 7 parts of eucalyptus globulus oil, 6 parts of platyphylla leaf oil, 5 parts of camphor, 5 parts of sweet orange oil and 5 parts of camphor tree leaf extract.
Further, the preparation raw materials of the inhalant composition also comprise the following components in parts by weight: 1 to 6 parts of cassia oil, 1 to 5 parts of patchouli oil, 1 to 5 parts of citrus peel extract, 0.2 to 2 parts of rosemary leaf oil, 0.2 to 2 parts of lemon peel oil, 0.2 to 2 parts of citral, 0.2 to 2 parts of citronellol, 0.2 to 2 parts of litsea cubeba oil, 0.2 to 2 parts of clove oil, 0.2 to 2 parts of lysimachia foenum-graecum extract, 0.2 to 2 parts of artificial musk, 0.2 to 2 parts of amyl acetate and 0.2 to 2 parts of ethyl acetate.
In practice, the inhalant composition is found to be added with the components such as cassia oil, patchouli oil, citrus peel extract and the like, so that the fragrance of each component can be fused and coordinated with each other, the traditional single fragrance type inhalant composition is richer in fragrance, and the inhalant composition is widely accepted and favored in human trial experiments.
Preferably, the raw materials for preparing the inhalant composition also comprise the following components in parts by weight: 1 to 4 parts of cassia oil, 1 to 3 parts of patchouli oil, 1 to 3 parts of citrus peel extract, 0.5 to 2 parts of rosemary leaf oil, 0.5 to 2 parts of lemon peel oil, 0.5 to 2 parts of citral, 0.5 to 2 parts of citronellol, 0.5 to 2 parts of litsea cubeba oil, 0.5 to 2 parts of clove oil, 0.5 to 2 parts of lysimachia foenum-graecum extract, 0.5 to 2 parts of artificial musk, 0.2 to 1 part of amyl acetate and 0.2 to 1 part of ethyl acetate.
More preferably, the raw materials for preparing the inhalant composition also comprise the following components in parts by weight: 3 parts of cassia oil, 2 parts of patchouli oil, 2 parts of citrus peel extract, 1 part of rosemary leaf oil, 1 part of lemon peel oil, 1 part of citral, 1 part of citronellol, 1 part of litsea cubeba oil, 1 part of clove oil, 1 part of lysimachia foenum-graecum extract, 1 part of artificial musk, 1 part of amyl acetate and 1 part of ethyl acetate.
The application of the composition in preparing daily chemical products or medicines with the effects of refreshing and restoring consciousness also falls into the protection scope of the invention. Meanwhile, different types of daily chemical product auxiliary materials or medicine auxiliary materials can be added to prepare various products. Such as inhalants, etc.
In addition, the invention also provides a refreshing and anti-fatigue inhalant which takes the composition as a main active ingredient.
Further, the inhalant also comprises auxiliary materials which are allowed to be added in the pharmaceutical or cosmetic field.
Still further, the adjuvants include a solvent, a solubilizer, a penetration enhancer and an antioxidant.
Further, the preparation method of the inhalant comprises the following steps:
mixing the raw materials, stirring, filtering, adsorbing on fiber rod, assembling, inspecting, and packaging.
Further, the fiber rod is polyethylene terephthalate resin or low density polyethylene.
The invention has the following beneficial effects:
the refreshing and anti-fatigue inhalant composition is composed of turpentine, menthol, eucalyptus globulus oil, tiled gaultheria oil, camphor, sweet orange oil and camphor tree leaf extract according to a certain proportion, all the components have synergistic effect, even if the composition is inhaled through nose and does not directly contact skin, the refreshing and anti-fatigue inhalant composition can also have remarkable and lasting refreshing and anti-fatigue effects, has strong penetrability and richer fragrance, and is widely accepted and favored in human trial experiments.
Detailed Description
The present invention will be further described with reference to the following specific examples, which are not intended to limit the invention in any manner. Reagents, methods and apparatus used in the present invention are conventional in the art unless otherwise indicated.
Unless otherwise indicated, reagents and materials used in the following examples are commercially available.
Example 1 an inhalant for refreshing and relieving fatigue
The inhalant for refreshing and resisting fatigue is prepared from the following components in parts by weight:
45 parts of turpentine, 10 parts of menthol, 7 parts of eucalyptus globulus oil, 6 parts of phyllanthus urinaria leaf oil, 5 parts of camphor, 5 parts of sweet orange oil, 5 parts of camphor leaf extract, 3 parts of cinnamon oil, 2 parts of patchouli oil, 2 parts of citrus peel extract, 1 part of rosemary leaf oil, 1 part of lemon peel oil, 1 part of citral, 1 part of citronellol, 1 part of litsea cubeba oil, 1 part of clove oil, 1 part of lysimachia foenum-graecum extract, 1 part of artificial musk, 1 part of amyl acetate and 1 part of ethyl acetate.
The preparation method comprises the following steps:
mixing the raw materials, stirring, filtering, adsorbing on fiber rod, assembling, inspecting, and packaging.
Example 2 an inhalant for refreshing and relieving fatigue
The inhalant for refreshing and resisting fatigue is prepared from the following components in parts by weight:
40 parts of turpentine, 15 parts of menthol, 12 parts of eucalyptus globulus oil, 10 parts of phyllanthus urinaria leaf oil, 2 parts of camphor, 2 parts of sweet orange oil, 8 parts of camphor leaf extract, 6 parts of cinnamon oil, 1 part of patchouli oil, 5 parts of citrus peel extract, 2 parts of rosemary leaf oil, 2 parts of lemon peel oil, 2 parts of citral, 0.2 part of citronellol, 0.2 part of litsea cubeba oil, 0.2 part of clove oil, 0.2 part of lysimachia foenum-graecum hance extract, 2 parts of artificial musk, 0.2 part of amyl acetate and 2 parts of ethyl acetate.
The preparation process is referred to example 1.
Example 3 an inhalant for refreshing and relieving fatigue
The inhalant for refreshing and resisting fatigue is prepared from the following components in parts by weight:
50 parts of turpentine oil, 5 parts of menthol, 4 parts of eucalyptus globulus oil, 2 parts of bigelia leaf oil, 8 parts of camphor, 8 parts of sweet orange oil, 2 parts of camphor leaf extract, 1 part of cinnamon oil, 5 parts of patchouli oil, 1 part of citrus peel extract, 0.2 part of rosemary leaf oil, 0.2 part of lemon peel oil, 0.2 part of citral, 2 parts of citronellol, 2 parts of litsea cubeba oil, 2 parts of clove oil, 0.2 part of lysimachia foenum-graecum extract, 0.2 part of artificial musk, 2 parts of amyl acetate and 0.2 part of lysimachia foenum-graecum oil
And (3) ethyl acetate.
The preparation method refers to example 1.
Comparative example 1 an inhalant
Comparative example 1 is different from example 1 in that the addition of turpentine is not performed, menthol is increased to 55 parts, and other parameters and operations are referred to example 1.
Comparative example 2 an inhalant
Comparative example 2 is different from example 1 in that menthol was not added, turpentine was added to 55 parts, and other parameters and operations were referred to example 1.
Comparative example 3 an inhalant
Comparative example 3 is different from example 1 in that eucalyptus globulus oil is not added and turpentine is added to 52 parts, and other parameters and operations refer to example 1.
Comparative example 4 an inhalant
Comparative example 4 differs from example 1 in that the addition of Callicarpa kolomikta leaf oil was omitted and turpentine was increased to 51 parts, and other parameters and operations were referred to example 1.
Comparative example 5 an inhalant
Comparative example 5 is different from example 1 in that camphor is not added, turpentine is increased to 50 parts, and other parameters and operations are referred to example 1.
Comparative example 6 an inhalant
Comparative example 6 is different from example 1 in that sweet orange oil is not added and turpentine is added to 50 parts, and other parameters and operations are referred to example 1.
Comparative example 7 an inhalant
Comparative example 7 is different from example 1 in that the camphor tree leaf extract is not added, the turpentine is added to 50 parts, and other parameters and operations refer to example 1.
Test example 1 Effect of inhalant on hypnosis of mice by diphenhydramine
1. Experimental materials: inhalants prepared in examples 1 to 3 and comparative examples 1 to 7.
2. Subject: 110 SPF mice, 20. + -.2 g, male and female halves.
3. The experimental method comprises the following steps:
randomly dividing mice into a model group, examples 1-3 groups and comparative examples 1-7 groups, wherein each group comprises 10 mice, and immediately carrying out inhalation on each group of mice with a corresponding inhalant after each mouse is injected with 0.1mg/kg diphenhydramine subcutaneously, wherein the inhalation amount is 5 mu l, and the model group is given distilled water with the same amount as the inhalation amount; the number of mice that did not fall asleep within 30min and the latency of the mice that fell asleep (time from the injection of diphenhydramine to the falling asleep) were recorded, and the rate of insomnia was calculated.
4. The experimental results are as follows: see table 1.
TABLE 1 Effect of inhalants on hypnosis in mice by diphenhydramine
Group of Mice not falling asleep (Only) Rate of non-sleep (%) Latency (min)
Model set 0 0 4.12±0.98
Example 1 4 40 17.33±3.64 **
Example 2 3 30 16.95±3.87 **
Example 3 4 40 17.06±3.71 **
Comparative example 1 1 10 8.18±3.05 *
Comparative example 2 2 20 10.07±2.93 *
Comparative example 3 1 10 8.74±3.36 *
Comparative example 4 2 20 9.76±3.17 *
Comparative example 5 1 10 9.41±3.28 *
Comparative example 6 2 20 9.87±3.66 *
Comparative example 7 1 10 9.23±2.85 *
Note: in comparison with the set of models, * P<0.05, ** P<0.01。
as can be seen from table 1, the inhalant prepared in the embodiments 1 to 3 of the present invention can significantly prolong the time for mice to sleep after injecting diphenhydramine, and even 30 to 40% of mice can not fall asleep, so that the mouse hypnotic effect caused by diphenhydramine can be effectively weakened, the refreshing effect is significant, and the effect is durable; the inhalants prepared in comparative examples 1 to 7 (without turpentine, menthol, eucalyptus globulus oil, kombu leaf oil, camphor, sweet orange oil and camphor leaf extract respectively) have remarkably shortened latency and remarkably reduced insomnia rate.
Test example 2 Effect of inhalant on mouse endurance
1. Experimental materials: inhalants prepared in examples 1 to 3 and comparative examples 1 to 7.
2. Subjects: 110 SPF mice, 20. + -.2 g, male and female halves.
3. The experimental method comprises the following steps:
randomly dividing mice into a model group, example 1-3 groups and comparative example 1-7 groups, wherein each group comprises 10 mice, each group of mice smells corresponding inhalants respectively, and the amount of the inhalants is 5 mu l, wherein the model group is provided with distilled water with the same amount of the inhalants; immediately after sniffing, the mice were placed on a rotary rod fatigue tester at a rotation speed of 20r/min, and the time of the mice's movement on the rod (from putting on the rotary rod to falling due to fatigue) was observed and recorded to evaluate the endurance of the mice.
4. The experimental results are as follows: see table 2.
TABLE 2 Effect of inhalants on mouse endurance
Group of Time of activity on stick (min)
Model set 2.61±0.58
Example 1 8.22±1.27 **
Example 2 7.89±1.18 **
Example 3 8.05±1.42 **
Comparative example 1 4.64±1.05 *
Comparative example 2 5.62±1.13 *
Comparative example 3 4.87±1.59 *
Comparative example 4 5.11±1.36 *
Comparative example 5 5.05±1.47 *
Comparative example 6 5.34±1.21 *
Comparative example 7 4.96±1.65 *
Note: in comparison with the set of models, * P<0.05, ** P<0.01。
as can be seen from Table 1, the inhalant prepared in the embodiments 1 to 3 of the present invention can significantly prolong the time of the mouse moving on the rod rotating fatigue apparatus, improve the rod rotating endurance of the mouse, and has a good anti-fatigue effect and a long lasting effect; the mice of the inhalants prepared in comparative examples 1 to 7 (respectively without turpentine, menthol, eucalyptus globulus oil, kombu leaf oil, camphor, sweet orange oil and camphor leaf extract) have remarkably shortened activity time on a rotating rod fatigue tester and weakened anti-fatigue effect.
Test example 3 inhalant stability measurement
After the inhalants in examples 1 to 3 were placed in an incubator with a relative humidity of 75% at 37. + -.1 ℃ for 90 days, whether the sensory properties such as flavor of the inhalant were changed or not was observed, and the influence of the inhalant on the hypnosis of mice by diphenhydramine was measured with reference to example 1, and the experimental results are shown in Table 3.
TABLE 3 Effect of inhalants on hypnosis in mice induced by diphenhydramine after 90 days of storage
Figure BDA0002539676650000081
Note: in comparison with the set of models, * P<0.05, ** P<0.01。
as can be seen from table 3, the inhalant prepared in the embodiment of the present invention has almost the same refreshing effect after being placed for 90 days, and has good stability, and the sensory properties such as flavor and the like are not significantly different from those of the inhalant when being placed for 0 day.
Test example 4 inhalant fragrance retention test measurement
100 testers were randomly arranged by using a sensory evaluation method, and the inhalants prepared in examples 1 to 3 and comparative examples 1 to 7 were scored; the evaluation method is that the liquid in the inhalant is dipped on the fragrance smelling strip, and each inhalant is tested for three times according to the standard that the fragrance retention time is more than or equal to 0 and less than 1h and 0 minute, the fragrance retention time is more than or equal to 1h and less than 1h and 1-3 minutes, the fragrance retention time is more than or equal to 1h and less than 4h and less than 7h and 4-6 minutes, the fragrance retention time is more than or equal to 7h and less than 10h and 9 minutes, and the fragrance retention time is more than or equal to 10 hours and 10 minutes, and the average value of the three times is taken as the final score, and the adjacent two times are separated by one day. The fragrance retention time test results are shown in table 4.
Table 4 inhalant fragrance retention test assay
Group of For the first time For the second time The third time Average score
Example 1 10 10 10 10
Example 2 10 9 10 9.6
Example 3 9 10 10 9.6
Comparative example 1 9 8 9 8.7
Comparative example 2 9 8 8 8.3
Comparative example 3 9 9 8 8.7
Comparative example 4 8 9 8 8.3
Comparative example 5 9 9 10 9.3
Comparative example 6 9 9 9 9.0
Comparative example 7 10 9 8 9.0
The inhalants prepared in the examples 1 to 3 of the present invention have fused and coordinated flavors, and have a long fragrance-retaining time and a long lasting fragrance, while the inhalants prepared in the comparative examples 1 to 7 have a short fragrance-retaining time.
Test example 5 measurement of indicators of microorganisms and toxic substances in inhalant
The inhalants prepared in examples 1 to 3 were subjected to microbiological and toxic substance index measurement, and the detection indexes are shown in table 5.
TABLE 5 determination of inhalant microorganism and toxic substance indexes
Figure BDA0002539676650000091
Experimental results show that the inhalants prepared in the embodiments 1-3 completely meet the standard requirements.
Test example 6 trial effect of inhalant on population
1. Test materials: inhalants prepared in examples 1 to 3 and comparative examples 1 to 7 were commercially available inhalants (hydrangea macrophylla, thailand).
2. Test subjects: the volunteers between 20 and 45 years old have symptoms of fatigue, drowsiness, low mood, inattention and the like.
3. The test method comprises the following steps:
the volunteers used the inhalants prepared in examples 1 to 3 and comparative examples 1 to 7 and commercially available inhalants in the case of fatigue, drowsiness, and inattention, and scored from the fragrance, cooling sensation, refreshing effect, duration, and comprehensive experience of the products, respectively, for 1 to 5 points.
4. The experimental results are as follows: see table 6.
TABLE 6 trial Effect for inhalant population
Group of Fragrance Feeling of coolness Refreshing effect Durability of Comprehensive experience Total score
Example 1 4.8 4.7 4.8 4.6 4.7 23.6
Example 2 4.6 4.5 4.6 4.4 4.5 22.6
Example 3 4.7 4.6 4.7 4.5 4.6 23.1
Comparative example 1 4.2 4.2 2.8 2.7 3.1 17.0
Comparative example 2 3.9 3.9 3.6 3.8 3.8 19.0
Comparative example 3 3.6 4.2 3.1 3.3 3.6 17.8
Comparative example 4 3.7 4.1 3.5 3.7 3.7 18.7
Comparative example 5 4.2 3.8 3.3 3.5 3.7 18.5
Comparative example 6 3.4 4.2 3.8 3.9 3.6 18.9
Comparative example 7 4.1 3.9 3.4 3.4 3.5 18.3
Commercially available inhalant 4.2 4.1 3.3 2.5 3.5 17.6
As can be seen from table 6, the inhalants prepared in examples 1 to 3 of the present invention have high scores in the aspects of flavor, cooling feeling, refreshing effect, durability, etc., the total score is over 22 points, and compared with the inhalant sold on the market, the total score is higher, and part of the inhalants react with the test subjects, and the inhalants in examples 1 to 3 also have significant effects of preventing dizziness, carsickness, etc., and are favored by the majority of the test subjects; the inhalants prepared in comparative examples 1 to 7 (without turpentine, menthol, eucalyptus globulus oil, cacumen gaultheriae Galli oil, camphor, sweet orange oil, camphor leaf extract, respectively) had poor effects in fragrance, refreshing effect, persistence, etc., and had low scores.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such modifications are intended to be included in the scope of the present invention.

Claims (7)

1. The inhalant composition for refreshing and resisting fatigue is characterized by being prepared from the following raw materials in parts by weight: 40 to 50 parts of turpentine, 5 to 15 parts of menthol, 4 to 12 parts of eucalyptus globulus oil, 2 to 10 parts of spreading beautyberry leaf oil, 2~8 parts of camphor, 2~8 parts of sweet orange oil, 2~8 parts of camphor leaf extract, 1~6 parts of cinnamon oil, 1~5 parts of patchouli oil, 1~5 parts of citrus peel extract, 0.2 to 2 parts of rosemary leaf oil, 0.2 to 2 parts of lemon peel oil, 0.2 to 2 parts of citral, 0.2 to 2 parts of citronellol, 0.2 to 2 parts of litsea cubeba oil, 0.2 to 2 parts of clove oil, 0.2 to 2 parts of lysimachia foenum-graecum extract, 0.2 to 2 parts of artificial musk, 0.2 to 2 parts of amyl acetate and 0.2 to 2 parts of ethyl acetate.
2. The inhalant composition according to claim 1, wherein the inhalant composition is prepared from the following components in parts by weight: 42 to 46 parts of turpentine, 8 to 12 parts of menthol, 5 to 10 parts of eucalyptus globulus oil, 4~8 parts of beautyberry leaf oil, 3~6 parts of camphor, 3~6 parts of sweet orange oil, 3~6 parts of camphor leaf extract, 1~4 parts of cinnamon oil, 1~3 parts of patchouli oil, 1~3 parts of orange peel extract, 0.5 to 2 parts of rosemary leaf oil, 0.5 to 2 parts of lemon peel oil, 0.5 to 2 parts of citral, 0.5 to 2 parts of citronellol, 0.5 to 2 parts of litsea cubeba oil, 0.5 to 2 parts of clove oil, 0.5 to 2 parts of vanilla extract, 0.5 to 2 parts of artificial musk, 0.2 to 1 part of amyl acetate and 0.2 to 1 part of ethyl acetate.
3. Use of the composition of claim 1 or 2 for the preparation of a daily chemical product or a pharmaceutical product having a refreshing and anti-fatigue effect.
4. An inhalant for refreshing and relieving fatigue, which comprises the composition according to claim 1 or 2 as an active ingredient.
5. The inhalant as claimed in claim 4, wherein the inhalant further comprises excipients which are pharmaceutically or cosmetically acceptable for addition.
6. The inhalant as claimed in claim 4 or 5, wherein the inhalant is prepared by a method comprising the steps of:
mixing the raw materials, stirring, filtering, adsorbing on fiber rod, assembling, inspecting, and packaging.
7. The inhalant as claimed in claim 6, wherein the fiber rod is polyethylene terephthalate resin or low density polyethylene.
CN202010542999.8A 2020-06-15 2020-06-15 Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method Active CN111743946B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010542999.8A CN111743946B (en) 2020-06-15 2020-06-15 Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010542999.8A CN111743946B (en) 2020-06-15 2020-06-15 Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method

Publications (2)

Publication Number Publication Date
CN111743946A CN111743946A (en) 2020-10-09
CN111743946B true CN111743946B (en) 2022-11-04

Family

ID=72675238

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010542999.8A Active CN111743946B (en) 2020-06-15 2020-06-15 Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method

Country Status (1)

Country Link
CN (1) CN111743946B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732458B (en) * 2010-01-28 2011-06-01 严培元 Compound essential oil having functions of refreshing spirit, restoring consciousness and resisting fatigue, and wet tissue containing same
CN105963366A (en) * 2016-07-08 2016-09-28 上海中华药业南通有限公司 Brown balm and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
千金香沁醒精华露;湘G妆网备字2018001379;《国产非特殊用途化妆品备案服务平台》;20180723;1 *

Also Published As

Publication number Publication date
CN111743946A (en) 2020-10-09

Similar Documents

Publication Publication Date Title
CN108158869B (en) Antibacterial wet tissue liquid, wet tissue and preparation method of wet tissue
KR101077018B1 (en) Cosmetic Composition with Anti-stress and Relaxing Effect
CN102551218B (en) Quick smoking cessation atomizing cigarette with prolonged service life
KR20120131970A (en) Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same
CN112220102B (en) Electronic cigarette liquid containing hyaluronic acid and ectoine and preparation method thereof
CN105055549B (en) A kind of compound plant stacte of tranquilizing and allaying excitement and preparation method thereof
CN108635441A (en) Compound essential oil composition, its application and the product for improving sleep
Edwards The Aromatherapy Companion: Medicinal Uses/Ayurvedic Healing/Body-Care Blends/Perfumes & Scents/Emotional Health & Well-Being
KR101074955B1 (en) Perfume composition having aromatherapic effect
CN111759885A (en) Sophora flavescens composition, sophora flavescens gel and preparation method thereof
CN111700929B (en) Inhalant composition for refreshing and restoring consciousness, inhalant and preparation method
CN109106970A (en) A kind of car refreshes oneself, the air spray composition of sterilization and preparation method thereof
CN111743946B (en) Inhalant composition capable of refreshing and resisting fatigue, inhalant and preparation method
CN111686046B (en) Refreshing and consciousness restoring bead composition, bead and preparation method
KR101971574B1 (en) Cosmetic composition for improving sleep disorder or maintaining deep sleep comprising withania somnifera, morus australis and pure tea extracts
CN105902700B (en) A kind of composite essential oil and preparation method thereof for alleviating post-exercise muscle soreness
CN110051744B (en) Compound traditional Chinese medicine essential oil for treating insomnia
CN109432318B (en) Compound essential oil, application thereof and compound essential oil product
CN113332345A (en) Traditional Chinese medicine composition for soothing nerves and beautifying and preparation method thereof
KR102124581B1 (en) Composition for mental and physical rest containing distilled-extracts of mountain-cultivated ginseng
CN105496843A (en) Combined formulation of rose blended fumigating essential oil
CN109260255A (en) A kind of woody compound sunstroke prevention essential oil and preparation method thereof
CN1382400A (en) Cigarette without tobacco
CN108096491A (en) It is a kind of using borneol cinnamomum camphora as the fragrant plant stacte and its preparation process of monarch
CN114984121B (en) A Chinese medicinal composition with effects of refreshing and relieving fatigue, and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant